Judge Refuses To Nix Bristol-Myers' Sustiva Case

Law360, New York (January 15, 2010, 2:42 PM EST) -- A federal judge has shot down a bid by Mylan Pharmaceuticals Inc. and Matrix Laboratories Ltd. to throw out Bristol-Myers Squibb Co.’s suit alleging the companies have infringed its patent by seeking to gain federal approval of a generic version of HIV treatment Sustiva.

The defendants argued that the suit lacked subject matter jurisdiction because Bristol-Myers' patent was not listed in the U.S. Food and Drug Administration’s Orange Book, which identifies patents that have issued or have been filed in new drug applications, but Judge Joseph...
To view the full article, register now.